Pain

A New Tool in the Non-Surgical Spine Toolbox: DISCSEEL® Comes to NYC

Patients with discogenic back pain who’ve exhausted physical therapy, medications, and injections…what to do with these “gray zone” patients?

1 views

NANS 2026 Recap: From Last Resort to Precision Medicine

Tired of the same old pain management conversations? The North American Neuromodulation Society's 2026 Annual Meeting delivered exactly what the doctor ordered. Las Vegas, January 22-25. Neurosurgeons, pain specialists, orthopedic surgeons, engineers, and industry innovators gathered for a mastercla

1 views

New Era of Precision Back Pain Management?

The future of spine pain care and pain management is increasingly interventional, collaborative, and outcome-driven.

1 views

Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.

MARLBOROUGH, Mass., Oct. 17, 2025 / PRNewswire / -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Nalu Medical, Inc., a privately held medical technology company focused on developing and commercializing innovative and minimally invas

Vivex Biologics Treats First Patient in its Restore Trial Evaluating VIA Disc NP™ for Patients with Degenerative Disc Disease

MIAMI, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, a leader in developing and delivering innovative allografts, today announced that it has treated the first patient in its Restore U.S. clinical trial evaluating VIA Disc NP™ for patients with lumbar discogenic pain associated with degenerati

Toss the Gabapentin for Nerve Injury?

A new meta-analysis of gabapentinoids in four RCT suggests it may be time to put down the prescription pad.

The Glutes Don’t Lie, Open or Endoscopic!

Have you ever faced a patient clutching their butt and vaguely describing sciatic-like symptoms?

Viva Las Vegas (Pain-Free, Hopefully): PAINWeek 2025

Pack your loupes, your lidocaine, and maybe your poker face—PAINWeek 2025 September 2–5—head to Las Vegas.

Imrecoxib: A New NSAID Challenger Steps Into the TKA Ring

This COX-2 upstart performed exceedingly well in its first head-to-head comparison against opioids. Could Imrecoxib join Celecoxib in the Cox-2 inhibitor hall of fame? Check it out.

New Algorithm Brings Order to Discogenic Pain Chaos

Did these spine and pain doc just crack the code for diagnosing discogenic pain? At the very least, they have brought order to disc pain chaos. Check it out.

New OrthoCarolina Pain Protocol Eliminates Opioids?!

New study shows a way to eliminate opioid use for pain management in 5 common ortho procedures. Really interesting new study out of the OrthoCarolina Research Institute. A must read.

Does This Hurt? A Pain Archetypes Study

Does this hurt? New study, using machine learning and the team at HSS has defined important patient pain archetypes. Details here.